JAMA Ophthalmology
Variables Associated With Faricimab Treatment Durability in Neovascular Age-Related Macular Degeneration
By C K Tan, Benjamin Bakall, Adrian Hock Chuan Koh and 8 others.
Abstract
This post hoc analysis of 2 randomized clinical trials evaluates baseline and early treatment response factors associated with longer faricimab dosing intervals in patients with neovascular age-related macular degeneration.
Keywords
- Retinal Diseases and Treatments
- Open access
Source
Published in JAMA Ophthalmology. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
At a glance
- Journal
